Page last updated: 2024-08-24

sertraline and Cutaneous T-Cell Lymphoma

sertraline has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lynch, DR; Newby, LK; Washam, JB	1

Reviews

1 review(s) available for sertraline and Cutaneous T-Cell Lymphoma

Article	Year
QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature. Cardiology journal, 2012, Volume: 19, Issue:4 Topics: Antineoplastic Agents; Doxepin; Electrocardiography; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hypnotics and Sedatives; Hypokalemia; Long QT Syndrome; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Polypharmacy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin Neoplasms; Tachycardia, Ventricular; Time Factors; Torsades de Pointes; Vorinostat	2012

Article

Year

QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.

Cardiology journal, 2012, Volume: 19, Issue:4

Topics: Antineoplastic Agents; Doxepin; Electrocardiography; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hypnotics and Sedatives; Hypokalemia; Long QT Syndrome; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Polypharmacy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin Neoplasms; Tachycardia, Ventricular; Time Factors; Torsades de Pointes; Vorinostat

2012